Budesonide Induces Remission More Effectively Than Prednisone in a Controlled Trial of Patients With Autoimmune Hepatitis
Michael Peter Manns, Marek Woynarowski, Wolfgang Kreisel et al. · Gastroenterology · 2010
Cited by 442 works. doi:10.1053/j.gastro.2010.06.046 Open-access PDF
Authors
- Michael Peter Manns
- Marek Woynarowski
- Wolfgang Kreisel
- Yoav Lurie
- Christian Rust
- Elimelech Zuckerman
- Rainer Günther
- Rolf W. Hultcrantz
- Ulrich Spengler
- Ansgar Wilhelm Lohse
- Ferenç Szalay
- Martti A. Färkkilä
- Markus Proels
- Christian P. Strassburg
References
- A Multiple Testing Procedure for Clinical Trials
- Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis†
- Classification of chronic hepatitis: Diagnosis, grading and staging
- Clinical, Biochemical, and Histological Remission of Severe Chronic Active Liver Disease: A Controlled Study of Treatments and Early Prognosis
- International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
- CONTROLLED TRIAL OF PREDNISONE AND AZATHIOPRINE IN ACTIVE CHRONIC HEPATITIS
- Diagnosis and Management of Autoimmune Hepatitis
- Adaptive Sample Size Calculations in Group Sequential Trials
- CHARACTERISATION OF A NEW SUBGROUP OF AUTOIMMUNE CHRONIC ACTIVE HEPATITIS BY AUTOANTIBODIES AGAINST A SOLUBLE LIVER ANTIGEN
- Autoimmune Hepatitis